Ibutamoren

ID: ibutamoren

Aliases: MK-677, MK-0677, LUM-201, Nutrobal

Type: compound

Route/form: oral

Status: investigational_or_research

Evidence level: human RCT

Best data tier: human controlled/review

Support scope: human

Source types: case_report, human_rct

Linked sources: 4

Broad outcomes: Brain / mood / sleep, Fat loss / metabolic health, Hormones / fertility / sexual health, Muscle growth / performance / recovery, PEDs / AAS / thermogenics

Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.

Targets / mechanism

Optimization domains

Research basis

Limits, risks, and missing evidence

Risk flags

Linked papers, labels, and reviews

  1. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults
    human_rct / pubmed_mk677_older_adults_2008
    Two-year randomized trial of MK-677/ibutamoren in older adults.
  2. MK-677 reverses diet-induced catabolism
    human_rct / pubmed_mk677_catabolism_1998
    Randomized human study of oral GH secretagogue MK-677 in diet-induced catabolism.
  3. Prolonged oral treatment with MK-677 improves sleep quality in man
    human_rct / pubmed_mk677_sleep_1997
    Human sleep/GH-axis study for MK-677; useful because ghrelin/GH effects can include sleep architecture and appetite/glucose tradeoffs.
  4. LGD-4033 and MK-677 use impacts body composition and circulating biomarkers
    case_report / pubmed_lgd_mk677_case_report_2022
    Self-administration case report with body composition, lipid, liver enzyme, and hormone changes.